Download PDF
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Determinants and impact of alexithymia on quality of life in Parkinson's disease
A. Alvarado-Bolaños; A. Cervantes-Arriaga; L. Zuazua-Vidal; Ó. Esquivel-Zapata; Á. Alcocer-Salas; M. Rodríguez-Violante;
Neurologia. 2023;38:334-41
Continuous intestinal infusion of levodopa¿carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community
D. Santos-García; M.J. Catalán; V. Puente; F. Valldeoriola; I. Regidor; P. Mir; J. Matías-Arbelo; J.C. Parra; F. Grandas;
Neurologia. 2021;36:101-11
Beta-caryophyllene inhibits the permeability of the blood¿brain barrier in MPTP-induced parkinsonism
A.R. Ramos-Molina; A.R. Tejeda-Martínez; J.M. Viveros-Paredes; V. Chaparro-Huerta; M.F. Urmeneta-Ortíz; L.J. Ramírez-Jirano; M.E. Flores-Soto;
Neurologia. 2025;40:191-203